When administered intravesically, the interaction with FCS facilitates transepithelial delivery of CAST-crRNAa, rearranging tight junction proteins in bladder epithelium and enabling TAT-mediated cellular internalization and PDL1 expression regulation in tumor tissues. The gene discussed is CAST; the disease is neoplasm.